Lumida
/ATAI
⌘K
ATAI Life Sciences NV

ATAI Life Sciences NV

ATAI
$7.22USD+0.98%+0.07 today

MARKET CAP

2.7B

P/E (TTM)

FWD P/E

DAY RANGE

$7 – $7

52W RANGE

$3
$7

AI Summary

Stalk
StalkMedium

ATAI remains in a Stage 2 advancing structure with a strong long-term uptrend, but price is extended above rising EMAs in an extreme overbought context without Lockout Rally support. Short-term timing is neutral, so speculative entries are deferred until a shallow pullback into the 9 EMA/21 EMA offers an asymmetric setup.

  • Cash reserves of $430M extend runway into 2024 for 11 programs
  • Phase IIb dosing for VLS-01 done; topline data due Q4 2026
  • Extremely negative earnings yield and low book-to-price imply overvaluation
Full analysis →
Loading graphs…